Cefazedone

DB13778

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 548.43
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

796 Data
Probenecid The serum concentration of Cefazedone can be increased when it is combined with Probenecid.
Foscarnet The risk or severity of nephrotoxicity can be increased when Cefazedone is combined with Foscarnet.
Mannitol The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Cefazedone.
Tenofovir disoproxil Cefazedone may increase the nephrotoxic activities of Tenofovir disoproxil.
Tenofovir alafenamide Cefazedone may increase the nephrotoxic activities of Tenofovir alafenamide.
Tenofovir Cefazedone may increase the nephrotoxic activities of Tenofovir.
Picosulfuric acid The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Cefazedone.
Cyclosporine The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefazedone.
Icosapent The risk or severity of nephrotoxicity can be increased when Icosapent is combined with Cefazedone.
Cefotiam The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Cefazedone.
Mesalazine The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefazedone.
Cefmenoxime The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Cefazedone.
Cefmetazole The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Cefazedone.
Indomethacin The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefazedone.
Triamterene The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefazedone.
Cefpiramide The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Cefazedone.
Loracarbef The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Cefazedone.
Cefalotin The risk or severity of nephrotoxicity can be increased when Cefalotin is combined with Cefazedone.
Nabumetone The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefazedone.
Ketorolac The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefazedone.
Tenoxicam The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Cefazedone.
Celecoxib The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Cefazedone.
Cefotaxime The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Cefazedone.
Tolmetin The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Cefazedone.
Rofecoxib The risk or severity of nephrotoxicity can be increased when Rofecoxib is combined with Cefazedone.
Fenoprofen The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Cefazedone.
Valdecoxib The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Cefazedone.
Diclofenac The risk or severity of nephrotoxicity can be increased when Diclofenac is combined with Cefazedone.
Sulindac The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Cefazedone.
Bacitracin The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Cefazedone.
Amphotericin B The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefazedone.
Cephaloglycin The risk or severity of nephrotoxicity can be increased when Cephaloglycin is combined with Cefazedone.
Adefovir dipivoxil The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Cefazedone.
Pentamidine The risk or severity of nephrotoxicity can be increased when Pentamidine is combined with Cefazedone.
Mefenamic acid The risk or severity of nephrotoxicity can be increased when Mefenamic acid is combined with Cefazedone.
Naproxen The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefazedone.
Sulfasalazine The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Cefazedone.
Phenylbutazone The risk or severity of nephrotoxicity can be increased when Phenylbutazone is combined with Cefazedone.
Meloxicam The risk or severity of methemoglobinemia can be increased when Cefazedone is combined with Meloxicam.
Carprofen The risk or severity of nephrotoxicity can be increased when Carprofen is combined with Cefazedone.
Tacrolimus The risk or severity of nephrotoxicity can be increased when Tacrolimus is combined with Cefazedone.
Etacrynic acid The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Cefazedone.
Ceforanide The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Cefazedone.
Salicylic acid The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Cefazedone.
Acetylsalicylic acid The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefazedone.
Hydrochlorothiazide The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Cefazedone.
Balsalazide The risk or severity of nephrotoxicity can be increased when Balsalazide is combined with Cefazedone.
Cefditoren The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Cefazedone.
Atazanavir The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Cefazedone.
Colistimethate The risk or severity of nephrotoxicity can be increased when Colistimethate is combined with Cefazedone.
Cefuroxime The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Cefazedone.
Cefapirin The risk or severity of nephrotoxicity can be increased when Cefapirin is combined with Cefazedone.
Cefprozil The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Cefazedone.
Olsalazine The risk or severity of nephrotoxicity can be increased when Cefazedone is combined with Olsalazine.
Lumiracoxib The risk or severity of nephrotoxicity can be increased when Lumiracoxib is combined with Cefazedone.
Cefamandole The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Cefazedone.
Cefazolin The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Cefazedone.
Cefonicid The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Cefazedone.
Cefoperazone The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Cefazedone.
Cefoxitin The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Cefazedone.
Ceftizoxime The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Cefazedone.
Magnesium salicylate The risk or severity of nephrotoxicity can be increased when Magnesium salicylate is combined with Cefazedone.
Salsalate The risk or severity of nephrotoxicity can be increased when Salsalate is combined with Cefazedone.
Choline magnesium trisalicylate The risk or severity of nephrotoxicity can be increased when Choline magnesium trisalicylate is combined with Cefazedone.
Cefepime The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Cefazedone.
Cefacetrile The risk or severity of nephrotoxicity can be increased when Cefacetrile is combined with Cefazedone.
Cefpodoxime The risk or severity of nephrotoxicity can be increased when Cefpodoxime is combined with Cefazedone.
Antrafenine The risk or severity of nephrotoxicity can be increased when Antrafenine is combined with Cefazedone.
Aminophenazone The risk or severity of nephrotoxicity can be increased when Aminophenazone is combined with Cefazedone.
Antipyrine The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Cefazedone.
Tiaprofenic acid The risk or severity of nephrotoxicity can be increased when Tiaprofenic acid is combined with Cefazedone.
Lopinavir The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Cefazedone.
Etoricoxib The risk or severity of nephrotoxicity can be increased when Etoricoxib is combined with Cefazedone.
Hydrolyzed Cephalothin The risk or severity of nephrotoxicity can be increased when Hydrolyzed Cephalothin is combined with Cefazedone.
Cephalothin Group The risk or severity of nephrotoxicity can be increased when Cephalothin Group is combined with Cefazedone.
Oxyphenbutazone The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Cefazedone.
Latamoxef The risk or severity of nephrotoxicity can be increased when Latamoxef is combined with Cefazedone.
Nimesulide The risk or severity of nephrotoxicity can be increased when Nimesulide is combined with Cefazedone.
Benoxaprofen The risk or severity of nephrotoxicity can be increased when Benoxaprofen is combined with Cefazedone.
Metamizole The risk or severity of nephrotoxicity can be increased when Metamizole is combined with Cefazedone.
Zomepirac The risk or severity of nephrotoxicity can be increased when Zomepirac is combined with Cefazedone.
Ceftobiprole The risk or severity of nephrotoxicity can be increased when Ceftobiprole is combined with Cefazedone.
Cimicoxib The risk or severity of nephrotoxicity can be increased when Cimicoxib is combined with Cefazedone.
Ceftaroline fosamil The risk or severity of nephrotoxicity can be increased when Ceftaroline fosamil is combined with Cefazedone.
Lornoxicam The risk or severity of nephrotoxicity can be increased when Lornoxicam is combined with Cefazedone.
Zaltoprofen The risk or severity of nephrotoxicity can be increased when Zaltoprofen is combined with Cefazedone.
Azapropazone The risk or severity of nephrotoxicity can be increased when Azapropazone is combined with Cefazedone.
Parecoxib The risk or severity of nephrotoxicity can be increased when Parecoxib is combined with Cefazedone.
Salicylamide The risk or severity of nephrotoxicity can be increased when Salicylamide is combined with Cefazedone.
Kebuzone The risk or severity of nephrotoxicity can be increased when Kebuzone is combined with Cefazedone.
Isoxicam The risk or severity of nephrotoxicity can be increased when Isoxicam is combined with Cefazedone.
Indoprofen The risk or severity of nephrotoxicity can be increased when Indoprofen is combined with Cefazedone.
Ibuproxam The risk or severity of nephrotoxicity can be increased when Ibuproxam is combined with Cefazedone.
Floctafenine The risk or severity of nephrotoxicity can be increased when Floctafenine is combined with Cefazedone.
Fenbufen The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefazedone.
Etofenamate The risk or severity of nephrotoxicity can be increased when Etofenamate is combined with Cefazedone.
Epirizole The risk or severity of nephrotoxicity can be increased when Epirizole is combined with Cefazedone.
Cefaloridine The risk or severity of nephrotoxicity can be increased when Cefaloridine is combined with Cefazedone.
Cefminox The risk or severity of nephrotoxicity can be increased when Cefminox is combined with Cefazedone.
Dexibuprofen The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefazedone.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul